Translational analysis from SCALOP trial: CCL5 as a prognostic biomarker and a potentially actionable target in locally advanced pancreatic cancer (LAPC)
Mukherjee S., Lanfredini S., Cox C., Thapa A., Hughes S., Bangs F., Willenbrock F., Wilhelm-Benartzi C., Abraham AG., Owens R., Sabbagh A., Maughan T., Hurt C., O'Neill E.